In the course of experimental work on the problem of autologous plasma clot suture of nerves (1), the desirability of in vitro tests of plasma clots became apparent and an instrument and method which might serve the purpose were devised. Since the procedure seemed likely to be useful to other workers, it was reported (2) while we were still accumulating the data now presented.
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Methods for measuring the tensile strength of clots have been used previously. Fonio (3) centrifuged 6 cc. quantities of blood mixed with 2 cc. of 0.75 per cent MgSO, to retard clotting, allowed spontaneous clotting of the supernatant ,plasma, then cut the plasma clot free of the cellular portion below. After compressing the clot in a special press to a 0.5 X 1.0 cm. disc, it was fixed in ether and then clipped above and below in its shorter dimension. Weights were then added until the clot broke and the maximal weight held recorded. The tensile strength of such fibrin discs was found to vary in individuals, the normal range being from about 250 to 350 grams. In diseased individuals, he found that the values obtained were often greater or less than the normal (4) . He did not attempt to correlate this variation with any property or constituent of the blood. Kristenson (5) given time, this was expressed in relation to its strength at 3 minutes taken as a base (a). Figure 1 shows the relative increment in clot tensile strength with the age of the clot. It can be seen that there is an increase in strength until the age of the clot reaches 20 minutes, after which there is hardly any change. Table I gives the data obtained from the study of 1-1 -normal human subjects (of ages 6 to 53 years). Specimens 1, 4, and 7 were from healthy young blood donors; 2, 3, and 10 were from healthy males who had undergone minor surgical procedures on the hospital ward; 5, 6, and 9 were from laboratory workers; 8 and 11 were from females studied in the Out-Patient Department and reported as free of organic disease.
RESULTS

I. Normal variations in clot tensile strength
The Incidentally, the elastic properties of plasma clots are well illustrated by the fact that equal increments in the weight load produce approximately equal increases in the length of the clot. With normal specimens, the average increase in length with every 10 gram increment was approximately 0.2 cm. With regard to the ability of the clot to resume its original length when the weights are removed, we have observed this to be only partial. The greater the load, the more pronounced is the disparity between the original and the recontracted lengths, with both retracted and non-retracted clots. This would indicate that the traction had produced permanent changes in the clot, one factor probably being the occurrence of irreversible intra-molecular transformations. These observations are in accord with the elastic properties that have been ascribed to protein gels in general (7) .
II. The relation of fibrinogen content of blood plasma to the tensile strength of the clot The conclusions to be presented are based on experiments on 30 human subjects (Tables I and  II) and 10 animals (2 rabbits, 4 dogs, 4 monkeys). Blood was drawn as previously described, but 10 cc. of blood were placed in a separate tube containing 10 mgm. of sodium oxalate, and the plasma fibrinogen was at once determined in duplicate by the method of Cullen and van Slyke. In almost half of the human cases, specimens of the chilled unmodified plasma were withdrawn for fibrinogen determination at the same time that the remaining portion was distributed into tubes for clotting.
This was done as a control and demonstrated that the handling of the blood in the manner described resulted in no loss of fibrinogen. The values in the latter determination were somewhat higher, as expected, due to the absence of oxalate and cells, and the avoidance of water-shift from cells to plasma (cf. second column under "fibrinogen," Table II ). The data for both human and animal subjects are plotted in Figure 2 . Inspection of the figure demonstrates at once that a marked correlation exists between the clot tensile strength and the fibrinogen content of the plasma, as is to be expected. Indeed, the coefficient of correlation of plasma fibrinogen with the clot tensile strength, based on the observations on the 30 human subjects, was found to be very high (equal to + 0.914 + 0.020).8 In fact, the fibrinogen content of the plasma could be estimated roughly from the tensile strength of the clot.
Further evidence of the dependence of tensile strength of plasma clots on the fibrinogen content was provided by the observation of Young and Medawar (8) that it is possible to strengthen the clots prepared from cockerel plasma by increasing the fibrinogen content (Mellenby's method). This method of fortifying unmodified plasma from human beings and rabbits we have found to be difficult because the plasma frequently clots before the fibrinogen can be dissolved in it. Fortification of human and rabbit heparinized plasma is more feasible and the tensile strength of the clots formed from such plasma is greater than if no extra fibrinogen is added.
DISCUSSION
The main point demonstrated by our study is that there is a very definite correlation between the tensile strength of clots and the level of available fibrinogen in the plasma. The variation in tensile strength of clots formed from subjects with similar plasma fibrinogen levels must depend in large part on the combined experimental errors of the two methods of study. That the scatter may also be due to other factors such as variations in the amount of thromboplastic substances, calcium, and anticoagulant substances present, cannot be excluded.
As for the role of the platelets in the physical properties of the clot, it may be significant that the plasma of fowl (cockerel), whose blood contains nothing strictly analogous to the platelets of mammals, formed clots which were much less elastic. Incidentally, these clots were usually far weaker than should have been expected even when we used special methods of clamping and clipping the clots in order to prevent crushing. CONCLUSIONS 1. The tensile strength of clots formed from normal human plasma varies within a narrow range. The variation in clot tensile strength observed in normal human beings is probably due in part to experimental error and in part to differences in the concentration of plasma fibrinogen.
2. A correlation is shown to exist in humans, monkeys, dogs, and rabbits, between clot tensile strength and the amount of fibrinogen in the plasma. The correlation coefficient between the fibrinogen content of human plasma and the tensile strength of the clot formed from that plasma was found to be + 0.914 ± 0.020 in a series of 30 determinations.
